A new claims-based study of nearly 4,000 Mississippi Medicaid members finds that adherence to GLP-1 weight-loss drugs plummets within months, with younger age, Black race, and early-shortage initiation linked to the steepest declines.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.